Pyraclostrobin and tebuconazole compounded microcapsule suspending agent and preparation method thereof
A technology of microcapsule suspension and pyraclostrobin, which is applied in the field of microcapsule suspension compounded with pyraclostrobin and tebuconazole and its preparation, which can solve the problems of large environmental pollution and achieve less dosage , Enhanced adhesion, large spraying time interval
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1: 6% pyraclostrobin tebuconazole microcapsule suspension
[0031] pyraclostrobin 4%; tebuconazole 2%; the solvent is toluene, the dosage is 10%; the emulsifier is castor oil polyoxyethylene ether and nonylphenol polyoxyethylene ether, the dosage is 3% and 3% respectively; Capsule skin material selects gelatin, gum arabic and formaldehyde (concentration 37%) for use, and consumption is respectively 1%, gum arabic 1% and 2%; Glycol, consumption is 4%; Viscosity regulator selects xanthan gum for use, consumption 0.2%; Water selects tap water for use, surplus.
[0032] The preparation method is: add pyraclostrobin and tebuconazole into the solvent toluene to dissolve completely, add emulsifier and stir well, then add water and shear at high speed for 0.5 hours, then add gelatin and gum arabic solution, add acetic acid dropwise Adjust the PH value, keep it for 2 hours to 24 hours at a reaction temperature of 30°C to 80°C, cool and add formaldehyde to cross-link and...
Embodiment 2
[0033] Example 2: 20% pyraclostrobin tebuconazole microcapsule suspension
[0034] pyraclostrobin 10%; tebuconazole 10%; solvent selection of xylene and cyclohexanone, the dosage is 10% and 5% respectively; emulsifier selection of fatty alcohol polyoxyethylene ether and styrylphenol polyoxyethyl ether Ether, the consumption is 2% and 4% respectively; The capsule skin material selects formaldehyde (concentration 37%), urea, consumption is respectively 8% and 5%; Glycerol is selected as the agent, and the consumption is 4%; the viscosity regulator is selected from magnesium aluminum silicate, and the consumption is 1%;
[0035] The preparation method is: add pyraclostrobin and tebuconazole into xylene and cyclohexanone to dissolve completely, add emulsifier and stir well, then add water and shear at high speed for 0.5 hours, then add formaldehyde-urea mixed solution, Add hydrochloric acid dropwise to adjust the pH value to an appropriate value, raise the temperature to 70°C and...
Embodiment 3
[0036]Example 3: 30% pyraclostrobin tebuconazole microcapsule suspension
[0037] pyraclostrobin 10%; tebuconazole 20%; solvent selection of toluene and acetonitrile, the dosage is 15% and 10% respectively; emulsifier selection of nonylphenol polyoxyethylene ether and styrylphenol polyoxyethylene ether, dosage respectively 4% and 2%; the capsule skin material is selected from toluene diisocyanate, polyethylene glycol 400 and polyvinyl alcohol, and the consumption is 2%, 9% and 1% respectively;; the viscosity modifier is selected from xanthan gum, and the consumption is 0.1%; The warning color is selected from rose essence, and the consumption is 0.1%, and the antifreeze is selected from ethylene glycol, and the consumption is 4%; the water is selected from tap water, and the balance is used.
[0038] The preparation method is: add pyraclostrobin and tebuconazole into xylene, acetonitrile and toluene diisocyanate to dissolve completely, add emulsifier and stir well, then add wa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com